Ivantis Company
%20.jpg)
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Investors
(INV)%20.jpg)
Headquarters:
Irvine, California, United States
Funding Status:
Late Stage Venture
Investors Number:
16
Founded Date:
2007-01-01
Investor Type:
For Profit
Last Funding Type:
Series C
Employee Number:
101-250
Total Funding:
$132.4M
Industry:
Health Care, Health Diagnostics, Medical Device
Estimated Revenue:
$10M to $50M
Technology:
P4 Medicine